drugset / Trial / NCT04635007

Tranexamic Acid Versus Misoprostol in Reducing Blood Loss in Cesarean Section in Primigravida

NCT04635007

Phase 3 Completed 200 enrolled Cairo University
RandomizedParallel-groupDouble-blindSupportive care

Summary

The aim of the work is to compare the efficacy of preoperative IV tranexamic acid and rectal misoprostol in reducing blood loss in the elective cesarean section. Research question: In women undergoing elective cesarean section, is preoperative administration of IV tranexamic acid better than rectal misoprostol in reducing blood loss?

Timeline

Start
2021-01-01
Primary completion
2022-06-01
Completion
2022-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 800 ug Rectal
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.